No Prescription, No Cough Syrup: Centre Mandates Doctor’s Approval for Syrup Purchases Across India

India’s Union Ministry of Health and Family Welfare announced on June 9, 2026, that a doctor’s prescription will now be required to purchase cough syrups and other medicinal syrups from pharmacies across the country. The change, formalized through the Drugs (Fifth Amendment) Rules, 2026, amends the Drugs Rules, 1945, and aims to reduce self-medication, prevent misuse of ingredients such as antihistamines, sedatives, and codeine-based compounds, and improve patient safety. The new rules require pharmacies to verify prescriptions before dispensing the specified syrups, placing greater compliance responsibilities on drug retailers. The amendment follows growing concerns over unsupervised medicine use, particularly in a country where self-medication is common, and seeks to address risks like dependency, irrational consumption, and adverse health effects. Public health experts have largely supported the measure as a step toward rational drug use and better pharmacovigilance. However, pharmacists and consumer groups have raised concerns about increased inconvenience for patients, especially in rural and underserved areas where doctor access is limited. The amendment is part of a broader regulatory push by Indian authorities to strengthen drug quality, manufacturing standards, and patient safety. India, one of the world’s largest producers and exporters of medicines, has faced rising pressure to tighten oversight in both domestic and global markets. The government’s notification emphasizes patient safety, responsible medicine use, and accountability in the pharmaceutical supply chain. Certain cough syrups contain active ingredients that can cause drowsiness, dependency, or misuse if consumed improperly, prompting stricter controls.